Shanghai Hile Bio-tech Strategic Asset Allocation Index
Shanghai Hile Bio-tech strategic asset allocation index. Shanghai Hile Bio-tech (603718) has a Strategic Asset Allocation Index of 14.7% as of June 2023. Strategic assets (PP&E of CN¥177.59 Million plus long-term investments of CN¥-) total CN¥177.59 Million, measured against net assets of CN¥1.21 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603718 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanghai Hile Bio-tech (2012–2022)
Strategic asset allocation index of Shanghai Hile Bio-tech from 2012 to 2022. This chart shows how Shanghai Hile Bio-tech's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 14.7%, representing strategic assets of CN¥177.59 Million against net assets of CN¥1.21 Billion CNY. Check how tangible is Shanghai Hile Bio-tech's equity to evaluate the tangible quality of the company's equity base.
Shanghai Hile Bio-tech Strategic Asset Allocation Index by Year (2012–2022)
Shanghai Hile Bio-tech strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Hile Bio-tech from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603718 market cap.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 19.8% | CN¥219.45 Million | CN¥219.45 Million | CN¥- | CN¥1.11 Billion | ▼ -8.2 pp |
| 2021 | 27.9% | CN¥275.90 Million | CN¥275.90 Million | CN¥- | CN¥987.19 Million | ▼ -17.2 pp |
| 2020 | 45.2% | CN¥434.57 Million | CN¥434.57 Million | CN¥- | CN¥962.20 Million | ▼ -2.8 pp |
| 2019 | 48.0% | CN¥476.05 Million | CN¥476.05 Million | CN¥- | CN¥992.57 Million | ▼ -3.0 pp |
| 2018 | 51.0% | CN¥522.68 Million | CN¥497.91 Million | CN¥24.77 Million | CN¥1.03 Billion | ▼ -2.3 pp |
| 2017 | 53.3% | CN¥572.42 Million | CN¥457.78 Million | CN¥114.64 Million | CN¥1.07 Billion | ▲ +8.3 pp |
| 2016 | 45.0% | CN¥451.99 Million | CN¥441.99 Million | CN¥10.00 Million | CN¥1.01 Billion | ▲ +6.2 pp |
| 2015 | 38.7% | CN¥373.19 Million | CN¥373.19 Million | CN¥- | CN¥963.31 Million | ▼ -6.8 pp |
| 2014 | 45.5% | CN¥254.14 Million | CN¥254.14 Million | CN¥- | CN¥558.50 Million | ▲ +5.4 pp |
| 2013 | 40.1% | CN¥200.92 Million | CN¥200.92 Million | CN¥- | CN¥500.66 Million | ▼ -5.8 pp |
| 2012 | 45.9% | CN¥214.80 Million | CN¥214.80 Million | CN¥- | CN¥467.89 Million | — |